Green tea polyphenols: biology and therapeutic implications in cancer
- PMID: 17569617
- DOI: 10.2741/2435
Green tea polyphenols: biology and therapeutic implications in cancer
Abstract
Multiple lines of evidence, mostly from population-based studies, suggest that green tea consumption is associated with reduced risk of several human malignancies such as cancer and diabetes. Epigallocatechin-3-gallate (EGCG), a major polyphenol found in green tea, is a widely studied chemopreventive agent with potential anticancer activity. Green tea polyphenols inhibit angiogenesis and metastasis, and induce growth arrest and apoptosis through regulation of multiple signaling pathways. Specifically, EGCG regulates expression of VEGF, matrix metalloproteinases, uPA, IGF-1, EGFR, cell cycle regulatory proteins and inhibits NFk B, PI3-K/Akt, Ras/Raf/MAPK and AP-1 signaling pathways, thereby causing strong cancer chemopreventive effects. This review discusses the molecular mechanisms of green tea polyphenols and their therapeutic implications in cancer.
Similar articles
-
EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment.Adv Clin Chem. 2011;53:155-77. doi: 10.1016/b978-0-12-385855-9.00007-2. Adv Clin Chem. 2011. PMID: 21404918 Free PMC article. Review.
-
Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.Toxicol In Vitro. 2009 Aug;23(5):834-9. doi: 10.1016/j.tiv.2009.04.011. Epub 2009 May 3. Toxicol In Vitro. 2009. PMID: 19406223
-
Multitargeted therapy of cancer by green tea polyphenols.Cancer Lett. 2008 Oct 8;269(2):269-80. doi: 10.1016/j.canlet.2008.04.014. Epub 2008 May 22. Cancer Lett. 2008. PMID: 18501505 Free PMC article. Review.
-
Mechanisms of cancer prevention by green and black tea polyphenols.Anticancer Agents Med Chem. 2006 Sep;6(5):389-406. doi: 10.2174/187152006778226468. Anticancer Agents Med Chem. 2006. PMID: 17017850 Review.
-
Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.Cancer Lett. 2007 Jan 8;245(1-2):232-41. doi: 10.1016/j.canlet.2006.01.027. Epub 2006 Mar 6. Cancer Lett. 2007. PMID: 16519995
Cited by
-
Phytocompounds targeting epigenetic modulations: an assessment in cancer.Front Pharmacol. 2024 Mar 26;14:1273993. doi: 10.3389/fphar.2023.1273993. eCollection 2023. Front Pharmacol. 2024. PMID: 38596245 Free PMC article. Review.
-
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging.Arch Toxicol. 2023 Oct;97(10):2499-2574. doi: 10.1007/s00204-023-03562-9. Epub 2023 Aug 19. Arch Toxicol. 2023. PMID: 37597078 Free PMC article. Review.
-
Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer.Front Oncol. 2022 Mar 25;12:869672. doi: 10.3389/fonc.2022.869672. eCollection 2022. Front Oncol. 2022. PMID: 35402265 Free PMC article. Review.
-
B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy.Int J Mol Sci. 2021 Sep 28;22(19):10442. doi: 10.3390/ijms221910442. Int J Mol Sci. 2021. PMID: 34638779 Free PMC article. Review.
-
Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer.Int J Nanomedicine. 2020 Jun 19;15:4417-4429. doi: 10.2147/IJN.S243657. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32606686 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous